You can find some information about all this here. And, depending on
what information you need, contact us at the numbers and websites
below. We’re here to help.
People with diabetes facing financial difficulties as a result of the COVID-19 pandemic can access a free 90-day supply of insulin under Novo Nordisk Inc.’s enhanced Patient Assistance Program (PAP). If you’re experiencing job loss, termination of healthcare benefits, or COBRA extension due to the pandemic, you may be eligible.
For more information, visit NovoCare.com.
Disease-specific resources to help you manage through the pandemic can be found below. If you're a patient with concerns or questions, please contact your physician or healthcare provider.
The health and safety of our employees is our top priority so we can continue serving the patients who depend on us. We carefully consider local, state and federal government guidelines when determining COVID-19 related policies for our employees. A full COVID-19 vaccination is required for all employees and contractors at all of our US office locations, production facilities and R&D sites; and for our field-based employees unless they qualify for an exemption. Employees and contractors with approved exemptions will be subject to regular testing. We also continue to reinforce the importance of mask wearing, frequent testing, handwashing, social distancing and other important safety measures among all employees consistent with government guidance.
We remain committed to doing our part for the communities we serve. Under the umbrella of the WHO-backed COVAX initiative, UNICEF is leading the work to distribute billions of vaccines to healthcare workers and vulnerable populations across the globe – and Novo Nordisk is determined to help.
By supporting the COVAX initiative, we can help ensure that vaccines are donated and delivered to countries that need them, and we can help strengthen healthcare systems to ensure the protection of healthcare workers and populations.